Skip to content
TrialScanner

NCT06374264

Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder

No phase registeredEnrolling by invitationAZNCollaborator

Registry record

Lead sponsor
MedRhythms, Inc.
Conditions
Neuromyelitis Optica Spectrum Disorder
Primary completion
Sep 30, 2026Sponsor estimate
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Sponsor estimate: the sponsor registered this date in advance and can move it. A primary completion date is when the last participant is measured, not when results are announced.

Open NCT06374264 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06374264: Acceptability and Safety of... | TrialScanner